Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancer.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Edelman, MJ; Hodgson, L; Wang, X; Kratzke, RA; Vokes, EE

Published Date

  • June 1, 2012

Published In

Volume / Issue

  • 30 / 16

Start / End Page

  • 2019 - 2020

PubMed ID

  • 22473168

Pubmed Central ID

  • 22473168

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.41.4581

Language

  • eng

Conference Location

  • United States